trending Market Intelligence /marketintelligence/en/news-insights/trending/xzqxer2zygk4qcnikto4cg2 content esgSubNav
In This List

AbbVie tender offer closes

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


AbbVie tender offer closes

AbbVie Inc. said that 75,743,313 common shares were tendered to its tender offer, which expired May 29.

The North Chicago, Ill.-based pharmaceutical giant said it expects to buy back 71.4 million common shares, or about 4.5% of its outstanding stock, at $105 apiece for a cost of about $7.5 billion, excluding fees and expenses.